Promotes selective clearance of senescent cells in various tissues, including aged organs and pathological conditions [3] [4] [5]
Mistake 6: storing all supply as reconstituted solution Some researchers reconstitute their entire supply at once for convenience
majority of TBI and stroke studies Mice Used for transgenic Alzheimers models (APP, APP/PS1) and excitotoxicity studies Humans Multiple clinical trials in stroke, dementia, and TBI populations Cell culture Cortical neurons, hippocampal cultures, endothelial cells for mechanistic studies Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite over 1,000 preclinical studies and numerous clinical trials, Cerebrolysin faces substantial translational challenges that significantly limit its therapeutic utility
Reported side effects in available research and clinical use include fatigue, headaches, nausea, and injection site irritation generally mild, but again, incompletely characterized over long-term use